Your browser doesn't support javascript.
loading
TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma.
Yu, Jiongjie; Ling, Sunbin; Hong, Jiachen; Zhang, Lincheng; Zhou, Wei; Yin, Lu; Xu, Shengjun; Que, Qingyang; Wu, Yongfeng; Zhan, Qifan; Bao, Jiaqi; Xu, Nan; Liu, Yuchen; Chen, Kangchen; Wei, Xuyong; Liu, Zhikun; Feng, Tingting; Zhou, Lin; Xie, Haiyang; Wang, Shuai; Liu, Jimin; Zheng, Shusen; Xu, Xiao.
Afiliación
  • Yu J; Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Ling S; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, China.
  • Hong J; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China.
  • Zhang L; Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Zhou W; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, China.
  • Yin L; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China.
  • Xu S; Hangzhou Normal University, Hangzhou, China.
  • Que Q; Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Wu Y; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China.
  • Zhan Q; Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Bao J; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, China.
  • Xu N; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China.
  • Liu Y; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, China.
  • Chen K; Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Wei X; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, China.
  • Liu Z; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, China.
  • Feng T; Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Zhou L; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, China.
  • Xie H; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, China.
  • Wang S; Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Liu J; Zhejiang Chinese Medical University, Hangzhou, China.
  • Zheng S; Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
  • Xu X; Key Laboratory of Integrated Oncology and Intelligent Medicine of Zhejiang Province, Hangzhou, China.
J Immunother Cancer ; 11(11)2023 11 29.
Article en En | MEDLINE | ID: mdl-38030304
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido